Jay Caplan

@jcmeddev

Developing less invasive interventions to treat metabolic disease

Boston, MA
Vrijeme pridruživanja: svibanj 2013.

Tweetovi

Blokirali ste korisnika/cu @jcmeddev

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @jcmeddev

  1. proslijedio/la je Tweet
    1. velj

    Lots going on these days in the industry I love working in. My colleagues & and I look back on our 2019 predictions and speculate on some trends that we believe will propel the industry forward at the start of this new decade!

    Poništi
  2. proslijedio/la je Tweet
    31. sij

    Now that we're a month into 2020 and have reflected on JPM, and I are sharing some expectations and predictions for the healthcare industry.

    Poništi
  3. proslijedio/la je Tweet
    28. sij

    We’re delighted to announce a revolutionary new procedure for the treatment of : (Duodenal Mucosal Resurfacing) for more info visit:

    Poništi
  4. proslijedio/la je Tweet
    28. sij
    Poništi
  5. proslijedio/la je Tweet
    21. sij

    Presenting this Journal Club tomorrow: Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

    Poništi
  6. proslijedio/la je Tweet
    16. sij

    Review of data from 36 studies w/ n=349,529: “women w/ polycystic ovary syndrome () are more likely to have an eating or sleeping disorder & report decreased sexual satisfaction than those without PCOS.”

    Poništi
  7. proslijedio/la je Tweet
    12. sij

    The traditional regulated RCT is good for early evidence of safety and efficacy, but leaves enormous gaps in understanding the benefits and risks applied to larger populations in real world settings.

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    12. sij

    Properly done, RWE will vastly expand knowledge about medical products throughout the life cycle of the products, and it will enable a much better understanding of which treatments are best--information badly needed by patients, families and clinicians.

    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    10. sij
    Poništi
  10. proslijedio/la je Tweet
    8. sij

    Our Revita-1 study (12 month safety and effectiveness data) is featured on the cover of Gut ⁦⁩ from the current issue. Congrats to van Baar and other authors on the selection (⁦including ⁩ ⁦⁩ )

    Poništi
  11. proslijedio/la je Tweet
    22. pro 2019.

    Wonderful to see work complete 🇮🇳 Final touches in place - but a sneak preview!! Amazing work Let the awareness spread- this worthwhile cause isn’t copyrighted to anyone 😊

    , , i još njih 7
    Poništi
  12. proslijedio/la je Tweet
    24. pro 2019.

    Happy Holidays from the Fractyl team!

    Poništi
  13. 16. pro 2019.

    Children born to women with —short- and long-term impacts on health and development

    Poništi
  14. 16. pro 2019.

    Important new paper highlighting both and as reproductive disorders

    Poništi
  15. proslijedio/la je Tweet
    29. stu 2019.

    Recipient of lifetime achievement award Prof Hanif speaking about demystifying diabetes... congratulations!!

    Poništi
  16. proslijedio/la je Tweet
    29. stu 2019.

    The wonderful recipient of lifetime achievement award speaking about the Journey of a Slumdog researcher 👍👏

    Poništi
  17. proslijedio/la je Tweet
    6. pro 2019.

    Raising awareness on PCOS in the endocrine community - a metabolic, reproductive and psychological condition - Women with PCOS need health professionals with understanding across all features of PCOS

    Poništi
  18. proslijedio/la je Tweet
    28. stu 2019.

    For Thanksgiving, we are thankful for your support and for the amazing Fractyl team and collaborators dedicated to pioneering a new treatment that brings hope to patients with metabolic diseases.

    Poništi
  19. 26. stu 2019.

    UK Patients with type 2 diabetes could be treated with outpatient endoscopic procedure Revita DMR via

    Poništi
  20. 19. stu 2019.

    Fractyl's intestine-resurfacing device shows gains in HbA1c and liver fat, plus 2-year data ⁦

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·